IQVIA Holdings Inc. $IQV Shares Acquired by Shell Asset Management Co.

Shell Asset Management Co. grew its holdings in IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 78.7% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,256 shares of the medical research company's stock after purchasing an additional 4,077 shares during the quarter. Shell Asset Management Co.'s holdings in IQVIA were worth $1,459,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the business. Everpar Advisors LLC grew its holdings in IQVIA by 4.6% during the 2nd quarter. Everpar Advisors LLC now owns 1,404 shares of the medical research company's stock valued at $221,000 after purchasing an additional 62 shares in the last quarter. Ballentine Partners LLC grew its holdings in IQVIA by 4.9% during the 1st quarter. Ballentine Partners LLC now owns 1,477 shares of the medical research company's stock valued at $260,000 after purchasing an additional 69 shares in the last quarter. Independent Advisor Alliance grew its holdings in IQVIA by 4.2% during the 1st quarter. Independent Advisor Alliance now owns 1,801 shares of the medical research company's stock worth $318,000 after acquiring an additional 72 shares in the last quarter. Nemes Rush Group LLC grew its holdings in IQVIA by 15.0% during the 1st quarter. Nemes Rush Group LLC now owns 621 shares of the medical research company's stock worth $109,000 after acquiring an additional 81 shares in the last quarter. Finally, Forte Capital LLC ADV grew its holdings in IQVIA by 0.3% during the 2nd quarter. Forte Capital LLC ADV now owns 26,809 shares of the medical research company's stock worth $4,225,000 after acquiring an additional 92 shares in the last quarter. 89.62% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, insider Eric Sherbet sold 5,800 shares of the business's stock in a transaction that occurred on Wednesday, July 23rd. The shares were sold at an average price of $190.05, for a total value of $1,102,290.00. Following the sale, the insider directly owned 27,178 shares in the company, valued at $5,165,178.90. The trade was a 17.59% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Keriann Cherofsky sold 549 shares of IQVIA stock in a transaction that occurred on Wednesday, July 23rd. The stock was sold at an average price of $191.53, for a total transaction of $105,149.97. Following the completion of the transaction, the insider directly owned 2,910 shares in the company, valued at approximately $557,352.30. This trade represents a 15.87% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

Analyst Ratings Changes

IQV has been the subject of several recent analyst reports. Barclays raised their price objective on shares of IQVIA from $185.00 to $200.00 and gave the stock an "equal weight" rating in a report on Thursday, October 2nd. Truist Financial raised their price objective on shares of IQVIA from $209.00 to $235.00 and gave the stock a "buy" rating in a report on Wednesday, July 23rd. Jefferies Financial Group raised shares of IQVIA from a "hold" rating to a "buy" rating and raised their price objective for the stock from $195.00 to $225.00 in a report on Tuesday, September 9th. UBS Group raised their price target on shares of IQVIA from $185.00 to $225.00 and gave the stock a "buy" rating in a research report on Wednesday, July 23rd. Finally, Redburn Partners set a $214.00 price target on shares of IQVIA in a research report on Wednesday, September 3rd. Eighteen investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $233.05.

IQVIA Trading Down 0.1%

IQVIA stock opened at $200.60 on Thursday. The company has a quick ratio of 0.84, a current ratio of 0.84 and a debt-to-equity ratio of 2.45. The firm has a 50-day moving average price of $188.35 and a two-hundred day moving average price of $168.04. The firm has a market capitalization of $34.10 billion, a price-to-earnings ratio of 29.03, a PEG ratio of 2.21 and a beta of 1.32. IQVIA Holdings Inc. has a 52-week low of $134.65 and a 52-week high of $237.34.

IQVIA (NYSE:IQV - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The medical research company reported $2.81 EPS for the quarter, beating the consensus estimate of $2.77 by $0.04. The firm had revenue of $4.02 billion for the quarter, compared to analysts' expectations of $3.96 billion. IQVIA had a return on equity of 30.05% and a net margin of 7.88%.The firm's revenue was up 5.3% compared to the same quarter last year. During the same period last year, the firm earned $2.64 EPS. IQVIA has set its FY 2025 guidance at 11.750-12.050 EPS. Sell-side analysts expect that IQVIA Holdings Inc. will post 10.84 earnings per share for the current year.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IQVIA Holdings Inc. (NYSE:IQV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.